{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:41:30Z","timestamp":1761100890684,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2931,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.bbmt.2007.01.075","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T07:00:49Z","timestamp":1174546849000},"page":"373-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: An Evolving Concept"],"prefix":"10.1016","volume":"13","author":[{"given":"Mohamed A.","family":"Kharfan-Dabaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.01.075_bib1","first-page":"106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bbmt.2007.01.075_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.01.075_bib4","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.01.075_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2007.01.075_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.01.075_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.01.075_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cyto.b.20132","article-title":"Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: a multicentric international harmonization process","volume":"70","author":"Letestu","year":"2006","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.bbmt.2007.01.075_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","article-title":"ZAP-70 expression and prognosis in chronic lymphocytic leukaemia","volume":"363","author":"Orchard","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2007.01.075_bib11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJM200012143432402","article-title":"Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia","volume":"343","author":"Rai","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.01.075_bib12","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1200\/JCO.2005.12.051","article-title":"Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia","volume":"23","author":"Keating","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib13","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1200\/JCO.2005.12.516","article-title":"Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia","volume":"23","author":"Wierda","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4065\/81.8.1105","article-title":"Chronic lymphocytic leukemia: diagnosis and treatment","volume":"81","author":"Yee","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"2 Suppl 5","key":"10.1016\/j.bbmt.2007.01.075_bib15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2006.01.024","article-title":"Monoclonal antibody therapy for B-cell malignancies","volume":"33","author":"Cheson","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib16","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1182\/blood-2003-05-1549","article-title":"The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status","volume":"103","author":"Dreger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib17","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2005-05-1778","article-title":"Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia","volume":"106","author":"Gribben","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V82.4.1366.1366","article-title":"Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia","volume":"82","author":"Rabinowe","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO.1994.12.4.748","article-title":"Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results","volume":"12","author":"Khouri","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/sj.leu.2401201","article-title":"Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia","volume":"12","author":"Sutton","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.01.075_bib21","doi-asserted-by":"crossref","first-page":"948a","DOI":"10.1182\/blood.V104.11.3480.3480","article-title":"Rituximab, fludarabin and cyclophosphamide followed by high dose therapy with autologous stem cell rescue leads to high molecular remission rate in chronic lymphocytic leukemia patients but relapses are observed","volume":"104","author":"Trneny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib22","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/bjc.1998.381","article-title":"Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?","volume":"77","author":"Dreger","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2007.01.075_bib23","doi-asserted-by":"crossref","first-page":"45a","DOI":"10.1182\/blood.V104.11.146.146","article-title":"Early autologous stem cell transplantation (SCT) in genetically poor-risk chronic lymphocytic leukemia is feasible and effective: results from a prospective multicenter study (GCLLSG CLL3 Protocol)","volume":"104","author":"Dreger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2004-01-0298","article-title":"Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses","volume":"105","author":"Milligan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib25","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1994.12.12.2527","article-title":"Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies","volume":"12","author":"Darrington","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1705375","article-title":"Autologous stem cell transplantation in patients with chronic lymphocytic leukemia: the Finnish experience","volume":"37","author":"Jantunen","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0301-472X(00)00524-5","article-title":"A prospective study of positive\/ negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia","volume":"28","author":"Dreger","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/07357900500201418","article-title":"Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome","volume":"23","author":"Montillo","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bbmt.2007.01.075_bib29","doi-asserted-by":"crossref","first-page":"520a","DOI":"10.1182\/blood.V104.11.1879.1879","article-title":"Feasibility of autologous stem cell transplantation (ASCT) in chronic lymphocytic leukemia (CLL) patients treated with sequential fludarabine and campath-1H","volume":"104","author":"Tedeschi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib30","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1200\/JCO.2005.04.6037","article-title":"Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia","volume":"24","author":"Montillo","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib31","doi-asserted-by":"crossref","first-page":"45a","DOI":"10.1182\/blood.V104.11.147.147","article-title":"Minimal residual disease (MRD) kinetics after autologous stem cell transplantation for chronic lymphocytic leukemia (CLL) correlate to IgVH mutational status and predict post transplant outcome: real time ASO-IgH PRC results of the GCLLSG CLL3 Protocol","volume":"104","author":"Ritgen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib32","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1182\/blood-2005-09-3634","article-title":"Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia","volume":"107","author":"Moreno","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-124-3-199602010-00005","article-title":"HLA-identical sibling bone marrow transplants for chronic lymphocytic leukaemia","volume":"124","author":"Michallet","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.01.075_bib34","first-page":"474a","article-title":"Conventional HLA-identical sibling bone marrow transplantation is able to cure chronic lymphocytic leukemia","volume":"102","author":"Michallet","year":"2003","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2007.01.075_bib35","first-page":"S53","article-title":"Allotransplants and autotransplants in CLL","volume":"23","author":"Michallet","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bmt.1703548","article-title":"Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia","volume":"29","author":"Doney","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib37","first-page":"482a","article-title":"Stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL): outcome and prognostic factors after autologous and allogeneic transplants","volume":"98","author":"Esteve","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bmt.1702237","article-title":"Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia","volume":"25","author":"Pavletic","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib39","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1200\/JCO.2005.03.962","article-title":"Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the center for international blood and marrow transplant research","volume":"23","author":"Pavletic","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bmt.1705130","article-title":"Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease","volume":"36","author":"Toze","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.leu.2403745","article-title":"Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis","volume":"19","author":"Dreger","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.01.075_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.leu.2402905","article-title":"Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning","volume":"17","author":"Dreger","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.01.075_bib43","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","article-title":"Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group","volume":"21","author":"Schetelig","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib45","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2005.04.569","article-title":"Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia","volume":"23","author":"Sorror","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib46","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bbmt.2006.06.004","article-title":"Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia","volume":"12","author":"Brown","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib47","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/blood-2003-12-4321","article-title":"Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR","volume":"104","author":"Ritgen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib48","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1200\/JCO.2005.04.531","article-title":"Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia","volume":"23","author":"Moreno","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.01.075_bib49","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1158\/1078-0432.CCR-05-0941","article-title":"Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)","volume":"11","author":"Caballero","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2007.01.075_bib50","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1182\/blood-2005-08-3372","article-title":"Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study","volume":"107","author":"Delgado","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.01.075_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0140-6736(84)92564-9","article-title":"Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)","volume":"2","author":"Waldmann","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2007.01.075_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc1365","article-title":"Molecules and mechanisms of the graft-versus-leukaemia effect","volume":"4","author":"Bleakley","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1 Suppl 1","key":"10.1016\/j.bbmt.2007.01.075_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbmt.2005.10.025","article-title":"Adoptive transfer of allogeneic antigen-specific T cells","volume":"12","author":"Riddell","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.01.075_bib54","first-page":"5","article-title":"Current use and outcome of hematopoietic cell transplantation: part II-CIBMTR summary slides, 2005","volume":"12","author":"Pasquini","year":"2006","journal-title":"CIBMTR Newslett"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:27:39Z","timestamp":1761056859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1083879107001140"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.01.075","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: An Evolving Concept","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.01.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}